CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

ImmunityBio Fiscal Q1 2021 Earnings Report - CapyFin

ImmunityBio

IBRX · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 Q2 2025 Q1 2025 Q4 2024 +5.96%Q3 2024 -11.38%Q2 2024 -17.18%Q1 2024 +2.53%Q4 2023 +14.53%Q3 2023 -9.33%Q2 2023 -9.73%Q1 2023 -63.34%Q4 2022 -16.80%Q3 2022 +7.39%Q2 2022 -3.34%Q1 2022 -19.28%Q4 2021 -4.58%Q3 2021 -8.70%Q2 2021 -0.09%Q1 2021 +14.73%Q4 2020 +14.73%Q3 2020 -3.45%Q2 2020 +7.23%Q1 2020 +17.49%Q4 2019 +16.44%Q3 2019 +2.78%Q2 2019 +8.33%Q1 2019 -7.32%Q4 2018 +1.68%Q3 2018 +40.38%Q2 2018 -7.84%Q1 2018 +0.51%Q4 2017 -6.52%Q3 2017 -5.67%Q2 2017 +5.42%Q1 2017 +5.46%Q4 2016 -1.97%Q3 2016 +2.16%Q2 2016 -2.17%Q1 2016 +1.80%Q4 2015 -3.29%Q3 2015 -3.51%Q2 2015 -1.41%

May 14, 2021

•

Mar 31, 2021

ImmunityBio Q1 2021 Earnings Report

Previous year: $165K

Previous year: -$0.19

Previous year: $165K

Cash and Equivalents

ImmunityBio

Unlock previous datapoints

ImmunityBio

Unlock previous datapoints

Revenue by Segment

Other revenues Revenue

Unlock previous datapoints

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View ImmunityBio

ImmunityBio Revenue by Segment